Hydroquinone Therapeutic Cheat Sheet
hydroquinone
by Kamaria Nelson, MD on
Hydroquinone is the most commonly used depigmentation agent and is a first-line treatment for melasma.1Hydroquinone was available previously in over-the-counter products and is currently available in prescription formulations with common concentration ranges of 0.4 to 5%. Prescription strengths available in the United States include hydroquinone 2% and 4% cream and hydroquinone 2% gel.2,3 In Septe …
Eflornithine Hydrochloride Therapeutic Cheat Sheet
eflornithine
by Emily Murphy, MD on
Millions of patients experience unwanted facial hair, severely impacting their quality of life. Laser hair removal is often the treatment of choice, but this therapy is uncomfortable, requires multiple treatments, and risks pigmentary changes. Therefore, an effective topical therapy for reduction of unwanted hair is a valuable addition to our therapeutic repertoire. We continue our series, Therape …
Acitretin for Psoriasis | Therapeutic Cheat Sheet
acitretin
by Azam Qureshi, MD on
Pustular psoriasis can present quickly and pose a life-threatening emergency. Acitretin is the only systemic retinoid FDA-approved for treatment of psoriasis, specifically both pustular and severe plaque-type psoriasis.1Systemic retinoids such as acitretin are utilized heavily in dermatology, and practitioners must be knowledgeable about all of the FDA-approved and off-label applications as well a …
Thalidomide for Dermatologic Conditions | Therapeutic Cheat Sheet
Thalidomide
by Emily Murphy, MD on
Thalidomide was introduced in the 1950s as a “safe” sleeping medication; however, it quickly became vilified and was removed from the market for its severe teratogenic effects, most commonly phecomelia, or loss of arms and legs. Despite these devastating birth defects, thalidomide has a variety of indications for dermatologic conditions, with manageable side effects when used appropriately. We …
Oral Glycopyrrolate for Hyperhidrosis | Therapeutic Cheat Sheet
Glycopyrrolate for hyperhidrosis
by Azam Qureshi, MD on
Hyperhidrosis affects up to 4.8% of people in the United States, causing significant impacts in patient quality of life.1 Often times, the etiology of symptoms cannot be identified, resulting in a subset of disease termed “primary hyperhidrosis.” Symptoms may be focal or generalized. Because there is a scarcity of FDA-approved treatments for primary hyperhidrosis, treatment often requires a mu …